Combi Screen Malb/crea for the Detection of Microalbuminuria

Combiscreen® mALB/CREA is an essential tool for screening for microalbuminuria, particularly suited to at-risk patients, such as those with diabetes or hypertension. The test enables rapid, accurate assessment of albumin levels in urine, contributing to effective medical management.

Features

• Type of test: visual to detect microalbuminuria.
• Albumin/creatinine ratio for precise information.
• Results available in 60 seconds.
• Detection limit: 22 mg/L.
• No 24-hour sample collection required.
• Automatic interpretation possible with Urilyzer® 100 Pro.
• Designed specifically for healthcare professionals.

Delivery

• France : Direct delivery.
• Export (Europe and Africa) : Quote.